Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na,K-ATPase inhibitor with vasoconstrictor activity

American Journal of Hypertension

Volumn 9, Issue 10 I, 1996, Pages 982-990

  Bagrov, A Y ^a   Dmitrieva, R I ^a   Fedorova, O V ^a   Kazakov, G P ^a   Roukoyatkina, N I ^a   Shpen, V M ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

bufodienolides; digitalis like factors; human vasoconstriction; Na K ATPase inhibition

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BUFADIENOLIDE DERIVATIVE; DIGITALIS LIKE FACTOR; DIGOXIN; MARINOBUFAGENIN; OUABAIN; UNCLASSIFIED DRUG; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOREACTIVITY; LUNG ARTERY; MALE; PRIORITY JOURNAL; SARCOLEMMA; URINARY EXCRETION; VASOCONSTRICTION;

EID: 0029855843     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(96)00148-3     Document Type: Article

References (43)

1. Haddy FJ Overbeck HW The role of humoral agents in volume expanded hypertension Life Sci 19 1976 935 948
2. Hamlyn JM Ringel M Schaeffer JS A circulating inhibitor of the Na,K-ATPase associated with essential hypertension Nature 300 1982 650 652
3. Hamlyn JM Manunta P Ouabain digitalis-like factors and hypertension J Hypertens 10 suppl 7 1992 S99 S111
4. Kelly RA O'Hara DS Canessa ML Characterization of digitalis-like factors in human plasma. Interactions with Na,K-ATPase and cross-reactivity with cardiac glycoside-specific antibodies J Biol Chem 260 1985 11396 11405
5. Shaikh IM Lau BWC Siegfried BA Isolation of digoxin-like immunoreactive material from mammalian adrenal cortex J Biol Chem 266 1991 13672 13678
6. Barbier M Shroter H Meyer K Die Bufogenine des Paratoidensekrets von Bufo marinus (L) Schneider (in German) Helv Chim Acta d.42 1959 2486 2506
7. Flier JC Ouabain-like activity in toad skin and its implications for endogenous regulation of ion transport Nature 274 1978 285 287
8. Lichtstein DL Gati I Ovadia H Digitalis-like compounds in the toad Bufo viridis : interactions with plasma proteins J Cardiovasc Pharmacol 22 suppl 2 1993 S102 S105
9. Bagrov AY Roukoyatkina NI Fedorova OV Digitalis-like and vasoconstrictor properties of endogenous digoxin-like factor (s) from the venom of Bufo marinus toad Eur J Pharmacol 234 1993 165 172
10. Bagrov AY Roukoyatkina NI Pinaev AG Effects of two NaK-ATPase inhibitors, marinobufagenin ouabain, on isolated rat aorta Eur J Pharmacol 274 1995 151 158
11. Goto A Yamada K Ishii M Immunoreactivity of endogenous digitalis-like factors Biochem Pharmacol 41 1991 1261 1263
12. Kieval RS Butler VP Derguini F Cellular electrophysiologic effects of vertebrate digitalislike substances J Am Col Cardiol 11 1988 637 643
13. Schoner W Kirch U Sich B Purification and some properties of an inhibitor of the sodium pump from bovine adrenals cross-reacting with proscillaridin A antibodies (abst) Biol Chem Hoppe-Seyler 374 1993 SP 181
14. Naomi S Graves S Lazarus M Variation in apparent serum digitalis-like fcator levels with different digoxin antibodies The “immunological fingerprint” 4 1991 795 801
15. Lichtstein D Gati I Samuelov S Identification of digitalis-like compounds in human cataractous lenses Eur J Biochem 216 1988 261 268
16. Bagrov AY Dmitrieva RI Fedorova OV Endogenous digitalis in acute myocardial ischaemia/infarction (abst) Biol Chem Hoppe-Seyler 374 1993 SP 181
17. Bagrov A Dmitrieva R Roukoyatkina N Nature and importance of endogenous digitalis-like factors in acute myocardial ischemia (abst) J Mol Cell Cardiol 26 1994 P393
18. Bagrov AY Anderson DE Dmitrieva RI Endogenous bufodienolide Na,K-ATPase inhibitor in plasma volume expansion (abst) Hypertension 24 1994 407
19. Bagrov AY Fedorova OV Dmitrieva RI Endogenous marinobufagenin-like immunoreactive factor Na,K-ATPase inhibition during voluntary hypoventilation Hypertension 26 1995 781 788
20. Allen JC Narvan SS Kahn AM Na-K-ATRase in vascular smooth muscle Am J Physiol 250 1985 C536 C539
21. Gillis RA Quest JA The role of the nervous system in the cardiovascular effects of digitalis Pharmacol Rev 131 1980 19 97
22. Aprigliano O Hermsmeyer K In vitro denervation of the portal vein and caudal artery of the rat J Pharmacol Exp Ther 198 1975 568 577
23. Zelnik R Ziti LM Thin-layer chromatography. Chromatoplate analysis of the bufodienolides isolated from toad venom J Chromatorogr 9 1962 37 39
24. Lichtstein D Minc D Bourrit A Evidence for the presence of ouabain like compound in human cerebrospinal fluid Brain Res 325 1985 12 19
25. Koenigs E Knorr E Uber einige Derivate des Traubenzuskers und der Galactose (in German) Ber Deut Chem Ges 34 1901 385 396
26. Wulf G Kruger W Die Umzetzung vin α -Acetobromglukose mit den Silbersalzen Hydroxycarbonsauren (in German) Chem Ber 104 1971 1387 1398
27. Curd J Smith TW Jaton J-C The isolation of digoxin specific antibody and its use in the reversal of the effects of digoxin Proc Natl Acad Sci USA 68 1971 2401 2406
28. McKinney MM Parkinson A A simple non-chromatographic procedure to purify immunoglobulins from serum and ascites fluid J Immunol Meth 96 1987 271 278
29. Helsingius P Hemmila I Lovgren T Solid phase immunoassay of digoxin by measuring time resolved fluorescence Clin Chem 32 1986 1767 1769
30. Dixon IM Hata T Dhalla NS Sarcolemmal Na,K ATP-ase activity in congestive heart failure due to myocardial infarction Am J Physiol 262 1992 C664 C671
31. Janssens SP Kachoris C Parker WL Hypothalamic Na,K-ATPase inhibitor constricts pulmonary arteries of spontaneously hypertensive rats J Cardiovasc Pharmacol 22 1993 S42 S47
32. Mikkelsen E Andersson K-E Pedersen OL Effects of digoxin on isolated human peripheral arteries and veins Acta Pharmacol Toxicol 45 1979 249 256
33. Woolfson RG Hilton PJ Poston L Effects of ouabain and low sodium on contractility of human resistance arteries Hypertension 15 1990 583 590
34. Woolfson RG Graves J LaBella FS Effect of bufalin and pregnanes on vasoreactivity of human resistance arteries Biochem Biophys Res Commun 186 1992 1 7
35. Cress LW Freas W Haddy F Effects of bufalin in norepinephrine turnover in canine saphenous vein Hypertension 18 1991 516 522
36. Schoner W Endogenous digitalis-like factors Clin Exp Hypertens A14 1992 767 856
37. Bagrov AY, Fedorova OV, Dmitrieva RI, et al: Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anaesthetized dogs. Cardiovasc Res (in press).
38. Goto A Yamada K Ishii M Does digoxin-like immunoreactivity really represent the natriuretic hormone? Nephron 54 1990 99
39. Goto A Yamada K Ishii M Does digoxin-like immunoreactivity really represent the natriuretic hormone? Nephron 54 1990 100
40. Williams GH Dluhy RG Control of aldosterone secretion Genest J Kuchel O Hamet P Cantin M Hypertension 1983 McGraw-Hill New York 320 337
41. Takeda Y Miyamore I Takeda R Effect of sodium restriction on urinary excretion of 19-noraldosterone 1819-dihydrocorticosterone. newly identified mineralocorticoids in man J Clin Endocrinol Metab 74 1992 1195 1197
42. Eliades D Swindall B Johnston J Hemodynamic effects of bufalin in anesthetized dog Hypertension 13 1989 690 695
43. Pamnani MB Chen S Yuan CM Chronic blood pressure effects of bufalin. a sodium-potassium ATPase inhibitor, in rats Hypertension 23 suppl I 1994 I